Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$15.18
-2.1%
$15.84
$8.27
$30.10
$467.93M1.24646,594 shs252,983 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$14.47
+1.3%
$15.43
$8.17
$19.60
$506.97M1.92247,553 shs140,659 shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$1.36
-2.2%
$1.59
$1.24
$3.59
$135.15M1.37947,246 shs535,117 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$23.85
-3.0%
$28.01
$12.50
$37.77
$548.18M0.81320,068 shs729,986 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-2.06%+1.88%+0.20%+35.54%+35.29%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
+1.33%-3.73%-10.01%-11.06%+71.85%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-2.16%-6.85%-12.26%-26.49%-51.08%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-3.01%-1.24%-17.01%-3.99%+89.59%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$15.18
-2.1%
$15.84
$8.27
$30.10
$467.93M1.24646,594 shs252,983 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$14.47
+1.3%
$15.43
$8.17
$19.60
$506.97M1.92247,553 shs140,659 shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$1.36
-2.2%
$1.59
$1.24
$3.59
$135.15M1.37947,246 shs535,117 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$23.85
-3.0%
$28.01
$12.50
$37.77
$548.18M0.81320,068 shs729,986 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-2.06%+1.88%+0.20%+35.54%+35.29%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
+1.33%-3.73%-10.01%-11.06%+71.85%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-2.16%-6.85%-12.26%-26.49%-51.08%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-3.01%-1.24%-17.01%-3.99%+89.59%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$25.6769.08% Upside
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.78
Moderate Buy$19.2933.28% Upside
Stereotaxis Inc. stock logo
STXS
Stereotaxis
3.00
Buy$3.70172.06% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.67
Moderate Buy$38.4061.01% Upside

Current Analyst Ratings Breakdown

Latest STXS, TCMD, NPCE, and CLPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
UpgradeHold (C-)Hold (C+)
8/17/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Reiterated RatingOverweight
8/12/2026
Stereotaxis Inc. stock logo
STXS
Stereotaxis
Lower Price TargetBuy$5.00 ➝ $3.00
8/11/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Lower Price TargetBuy$40.00 ➝ $39.00
8/4/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Set Price Target$25.00
8/4/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Set Price Target$22.00
8/3/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Reiterated RatingHold (C-)
7/29/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Reiterated RatingNeutral
7/29/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Reiterated RatingBuy$20.00
7/23/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Initiated CoverageOutperform$22.00
7/17/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Reiterated RatingSell (D-)
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M12.52N/AN/A$0.99 per share15.33
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$99.99M4.97N/AN/A$0.57 per share25.39
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$32.38M4.11N/AN/A$0.14 per share9.71
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$329.52M1.64$1.14 per share21.01$9.80 per share2.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$1.18N/AN/AN/A-81.76%-188.09%-40.88%11/5/2026 (Estimated)
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$21.47M-$0.57N/AN/AN/A-19.34%-105.64%-16.51%11/3/2026 (Estimated)
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$21.64M-$0.28N/AN/AN/A-74.24%-130.84%-29.23%N/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$19.09M$1.0822.0817.93N/A7.10%11.49%9.17%11/2/2026 (Estimated)

Latest STXS, TCMD, NPCE, and CLPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.2179-$0.18+$0.0379-$0.18$22.61 million$22.83 million
8/11/2026Q2 2026
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$0.05-$0.05N/A-$0.05$8.35 million$7.67 million
8/10/2026Q2 2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.1350$0.34+$0.2050$0.34$85.52 million$85.70 million
8/3/2026Q2 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.2867-$0.38-$0.0933-$0.38$12.73 million$10.88 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
4.66
4.74
3.89
NeuroPace, Inc. stock logo
NPCE
NeuroPace
4.97
4.94
3.91
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/A
1.42
0.95
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/A
4.12
3.68

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
45.35%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
19.20%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
16.03%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11030.50 million28.39 millionOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17034.32 million27.73 millionOptionable
Stereotaxis Inc. stock logo
STXS
Stereotaxis
13097.93 million82.24 millionNot Optionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,08622.65 million22.18 millionOptionable

Recent News About These Companies

Tactile Systems Technology Q2 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$15.18 -0.32 (-2.06%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$15.19 +0.01 (+0.05%)
As of 06:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$14.47 +0.19 (+1.33%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$14.48 +0.01 (+0.10%)
As of 08/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Stereotaxis stock logo

Stereotaxis NYSEAMERICAN:STXS

$1.36 -0.03 (-2.16%)
Closing price 08/18/2026 04:10 PM Eastern
Extended Trading
$1.36 0.00 (-0.15%)
As of 06:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$23.85 -0.74 (-3.01%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$24.22 +0.38 (+1.57%)
As of 08/18/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.